Establishing metastatic prostate cancer quality indicators using a modified Delphi approach

Jia Zheng, Fanny Sampurno, Daniel J. George, Alicia K. Morgans, Hannah Nguyen, Janet L. Abrahm, Anders Bjartell, Ian D. Davis, Margaret I. Fitch, Silke Gillessen, Ravindran Kanesvaran, Andrew Matthew, Jeremy L. Millar, Joe M. O'Sullivan, Heather Payne, Frederic Pouliot, Patsy Yates, Sue M. Evans*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Downloads (Pure)


There is variation in the care provided to men with metastatic prostate cancer (mPCa). There has been no previous set of quality indicators (QIs) regarding the management of men with mPCa. The objective of this study is to develop a set of international mPCa-specific QIs, which will enable global benchmarking of quality of care.

Materials and methods
Potential QIs were identified through a literature review. Fourteen multidisciplinary mPCa experts (representing medical and radiation oncology, nursing, psychology, palliative care and urology) from eight countries participated in a modified Delphi process, which consisted of two online surveys, one face-to-face meeting and two teleconferences. Panellists were asked to rate each indicator's importance and feasibility on a Likert scale from 1-9. Indicators that received median importance and median feasibility scores ≥7.5, and a disagreement index <1 for both measures, on the final round of voting were included in the final set.

There was consensus on 23 QIs out of total of 662. Four regarding “general management”, 12 “therapies”, three “complications” and four “patient-reported quality of life”. One of the inherent limitations of the Delphi process is that there is a small expert panel involved.

The quality indicator set defined by our process for management of men with mPCa will enable greater understanding of the standard and variation of care globally and will promote consistency of good practice. Future directions will include retrospective evaluation for compliance with these indicators, as well as prospective monitoring.
Original languageEnglish
JournalClinical genitourinary cancer
Early online date07 Jan 2022
Publication statusEarly online date - 07 Jan 2022


Dive into the research topics of 'Establishing metastatic prostate cancer quality indicators using a modified Delphi approach'. Together they form a unique fingerprint.

Cite this